Mahnia Madan, OD, FAAO
Dr. Mahnia Madan is a graduate of Pacific University College of Optometry and did a residency in ocular disease and surgical co-management at the Eye Center of Texas in Houston. Dr. Madan is a fellow of the American Academy of Optometry and has lectured on the management of ocular diseases including dry eyes and glaucoma. She practices in Vancouver, BC where she splits her time between an ophthalmology and an optometry practice. Her practice focuses on the use of innovative treatments for advanced dry eye disease such as Platelet Rich Plasma (PRP) and Intense Pulse Light (IPL). She and her team developed the technique to make PRP eye drops in her Vancouver clinic. She also currently serves as President for the BC Doctors of Optometry in BC.
6
The Impact of Sleep on Dry Eye Disease—and Vice Versa
Discover how sleep impacts dry eye disease (DED), and the steps optometrists can take to manage DED and educate patients on their connection.
How Air Quality Affects Ocular Health
Discover how poor air quality can affect ocular health and tips optometrists can offer patients for protecting their eyes from air pollution.
Incorporating In-Office Dry Eye Treatments When At-Home Care Isn't Enough
At-home care combined with in-office treatments leads to much better results for patients than either one alone. Learn about the latest in-office options for dry eye disease.
What Doctors Think About the New Generic of Restasis
Restasis has been a go-to eye drop for dry eye disease for two decades. We interviewed four optometrists to see how they felt about the newly FDA-approved generic version of cyclosporine ophthalmic emulsion 0.05%, and this what they had to say.
The Dry Eye Content You Missed at Eyes On 2022
Missed Eyes On 2022? This largest virtual event of the year for ECPs featured some incredible sessions from leaders in the field of dry eye. Access on-demand recordings now.
Using Platelet-Rich Plasma Eye Drops In Dry Eye Therapy
Lubricating eye drops are common first-line therapies for dry eye, but no drops truly replicate the biochemistry of natural tears. Platelet rich plasma (PRP) could change all that.